Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schlag

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 1, 1991
[Multilocular, immature-cell myelogenous infiltrates of the skin in a patient with chronic myelomonocytic leukemia following polycythemia vera and anti-cardiolipin syndrome]C G Schirren, R Schlag, F Eckert, et al.
Environmental Research|January 1, 1995
Lead levels in the household environment of children in three high-risk communities in CaliforniaP M Sutton, M Athanasoulis, P Flessel, et al.
American Journal of Hematology|May 1, 1995
Decreased production of TNF and IL-6 in whole blood of CLL patientsE Dahlke, R Schlag, I Langenmayer, et al.
Bone|January 1, 1987
Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric studyR Burkhardt, G Kettner, W Böhm, et al.
Leukemia Research|January 1, 1990
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsivenessC Weiss, A D Ho, E Hiller, et al.
Leukemia|January 31, 2015
Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 studyV Goede, K Fischer, A Engelke, et al.
Leukemia|August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinantsR Hehlmann, M Lauseker, S Saußele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 1, 1991
[Multilocular, immature-cell myelogenous infiltrates of the skin in a patient with chronic myelomonocytic leukemia following polycythemia vera and anti-cardiolipin syndrome]C G Schirren, R Schlag, F Eckert, et al.
Environmental Research|January 1, 1995
Lead levels in the household environment of children in three high-risk communities in CaliforniaP M Sutton, M Athanasoulis, P Flessel, et al.
American Journal of Hematology|May 1, 1995
Decreased production of TNF and IL-6 in whole blood of CLL patientsE Dahlke, R Schlag, I Langenmayer, et al.
Bone|January 1, 1987
Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric studyR Burkhardt, G Kettner, W Böhm, et al.
Leukemia Research|January 1, 1990
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsivenessC Weiss, A D Ho, E Hiller, et al.
Leukemia|January 31, 2015
Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 studyV Goede, K Fischer, A Engelke, et al.
Leukemia|August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinantsR Hehlmann, M Lauseker, S Saußele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Pageof 2